| Organism name | Peperomia sui |
|---|---|
| Genus | Peperomia |
| Family | Piperaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Peperomia |
|---|---|
| Linked NCBI taxonomy ID | 13196 |
| Linked level | genus |
| Family in NCBI taxonomy | Piperaceae |
|---|---|
| ID | 16739 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | Magnoliophyta |
|---|---|
| ID | 3398 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00001016
|
7-O-Methylacacetin
/ Acacetin 7-methyl ether / Genkwanin 4'-methyl ether / Apigenin 7,4'-dimethyl ether / 5-Hydroxy-4',7-dimethoxyflavone / 5-Hydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL350958
|
C044998
|
1 / 0 / 0 | No. 3 | No. 15 |
|
|
|
C00003741
|
Betulinic acid
|
CHEMBL269277
CHEMBL71690 CHEMBL519059 CHEMBL1318530 CHEMBL2005635 |
C002070
|
34 / 17 / 14 | 10 / 2 | No. 23 | No. 51 |
|
|
C00003854
|
5-Hydroxy-7,8,4'-trimethoxyflavone
/ 5-Hydroxy-4',7,8-trimethoxyflavone / Isoscutellarein 7,8,4'-trimethyl ether / 5-Hydroxy-7,8-dimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one |
No. 35 | No. 15 |
|
||||
|
C00007190
|
(+)-Pinoresinol
|
CHEMBL267963
CHEMBL487611 CHEMBL460862 |
C103298
|
7 / 5 / 6 | No. 38 | No. 21 |
|
|
|
C00031274
|
Salidroside
/ Rhodioloside / (-)-Rhodioloside / Tyrosol alpha-(beta-D-glucopyranoside) |
CHEMBL465208
CHEMBL1899113 |
C009172
|
3 / 0 / 0 | No. 45 | No. 72 |
|
|
|
C00025324
|
N-cis-Feruloyltyramine
/ cis-N-Feruloyltyramine |
CHEMBL206555
CHEMBL451720 |
1 / 4 / 2 | No. 499 |
|
|||
|
C00000601
|
(+)-Sesamin
|
CHEMBL43469
CHEMBL252915 CHEMBL1572261 CHEMBL1591714 CHEMBL1708854 CHEMBL1904496 CHEMBL1968861 |
C054125
|
20 / 24 / 15 | 0 / 5 | No. 621 | No. 21 |
|
|
C00036311
|
(+)-Hinokinin
|
CHEMBL180970
CHEMBL182073 CHEMBL242011 |
2 / 1 / 1 | No. 629 | No. 21 |
|
||
|
C00003467
|
Phytol
/ trans-Phytol |
CHEMBL390773
CHEMBL1644111 |
D010836
|
0 / 5 | No. 641 | No. 38 |
|
|
|
C00025788
|
Cepharadione B
|
CHEMBL396085
|
C457230
|
No. 800 |
|
|||
|
C00029390
|
Phaeophorbide-a-methyl ester
/ Pheophorbide a' methyl ester / 13-epi-Phaeophorbide a methyl ester |
CHEMBL408290
CHEMBL504821 CHEMBL1985396 |
No. 990 |
|
||||
|
C00002682
|
Vanillic acid
/ 3-Methoxy-4-hydroxybenzoic acid |
CHEMBL120568
|
D014641
|
5 / 3 / 3 | 5 / 0 | No. 1073 |
|
|
|
C00000619
|
Eugenol
|
CHEMBL42710
|
D005054
|
103 / 45 / 36 | 152 / 28 | No. 1852 | No. 6 |
|
|
C00037616
|
Peperomin E
/ (+)-Peperomin E |
CHEMBL521941
|
3 / 2 / 3 | No. 1888 |
|
|||
|
C00030771
|
Methylparaben
/ p-Methoxycarbonylphenol |
CHEMBL325372
|
C015358
|
102 / 49 / 57 | 3 / 0 | No. 2169 |
|
|
|
C00037869
|
Surinone C
|
No. 3219 |
|
|||||
|
C00037689
|
Proctorione C
|
No. 3219 |
|
|||||
|
C00037867
|
Surinone A
|
CHEMBL227111
|
No. 3452 |
|
||||
|
C00037868
|
Surinone B
|
No. 3452 |
|
|||||
|
C00037579
|
Oleiferinone
|
CHEMBL227112
|
No. 3452 |
|
||||
|
C00011606
|
beta-Bisabolol
|
No. 4385 |
|
|||||
|
C00037866
|
Suranone
/ (+)-Suranone |
No. 8076 |
|
|||||
|
C00001179
|
Vitamin C
/ L-Ascorbate / L-Ascorbic acid / (+)-Ascorbic acid |
CHEMBL196
CHEMBL1161421 |
D001205
|
104 / 58 / 50 | 254 / 98 | No. 8774 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000601 C00000619 C00001179 C00003741 C00030771 C00036311 | 1 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000601 C00000619 C00001179 C00003741 C00030771 C00036311 | 0 / 1 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000601 C00000619 C00001179 C00003741 C00030771 | 1 / 1 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000601 C00000619 C00001179 C00003741 C00030771 | 0 / 1 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000619 C00001179 C00030771 C00031274 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00000619 C00001179 C00002682 C00030771 | 1 / 1 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000619 C00001179 C00003741 C00030771 | 0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00000601 C00000619 C00001179 C00030771 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00000601 C00000619 C00003741 C00031274 | 0 / 0 |
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00000619 C00001016 C00001179 C00030771 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000619 C00001179 C00007190 C00030771 | 0 / 3 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000619 C00001179 C00030771 | 2 / 0 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000619 C00001179 C00030771 | 2 / 2 |
| P08246 | Neutrophil elastase | S1A | C00000619 C00001179 C00030771 | 2 / 1 |
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000619 C00001179 C00030771 | 0 / 0 |
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00000601 C00002682 C00030771 | 0 / 0 |
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000619 C00001179 C00030771 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00000619 C00001179 C00030771 | 0 / 0 |
| P17252 | Protein kinase C alpha type | Alpha | C00000619 C00001179 C00030771 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00000619 C00001179 C00030771 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000601 C00001179 C00030771 | 0 / 0 |
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000619 C00001179 C00030771 | 1 / 1 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00000619 C00001179 C00030771 | 2 / 2 |
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P25105 | Platelet-activating factor receptor | PAF receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P25103 | Substance-P receptor | Neurokinin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00000619 C00001179 C00030771 | 1 / 2 |
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000619 C00001179 C00030771 | 0 / 1 |
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000619 C00001179 C00030771 | 1 / 1 |
| P25021 | Histamine H2 receptor | Histamine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P35367 | Histamine H1 receptor | Histamine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000619 C00001179 C00030771 | 1 / 0 |
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P06241 | Tyrosine-protein kinase Fyn | Src | C00000619 C00001179 C00030771 | 0 / 0 |
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000619 C00001179 C00030771 | 0 / 0 |
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P35372 | Mu-type opioid receptor | Opioid receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000619 C00001179 C00030771 | 1 / 8 |
| P22303 | Acetylcholinesterase | Hydrolase | C00000619 C00001179 C00030771 | 1 / 0 |
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000619 C00001179 C00030771 | 1 / 0 |
| P03956 | Interstitial collagenase | M10A | C00000619 C00001179 C00030771 | 0 / 1 |
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00000619 C00001179 C00030771 | 2 / 0 |
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000619 C00001179 C00030771 | 1 / 1 |
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000619 C00001179 C00030771 | 0 / 0 |
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000619 C00001179 C00030771 | 1 / 0 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000619 C00001179 C00030771 | 0 / 0 |
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000619 C00001179 C00030771 | 1 / 0 |
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000619 C00001179 C00030771 | 1 / 1 |
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000619 C00001179 C00030771 | 2 / 1 |
| P06239 | Tyrosine-protein kinase Lck | Src | C00000619 C00001179 C00030771 | 0 / 1 |
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000619 C00001179 C00030771 | 0 / 0 |
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000619 C00001179 C00030771 | 1 / 0 |
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000619 C00001179 C00030771 | 3 / 0 |
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P21452 | Substance-K receptor | Neurokinin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P08311 | Cathepsin G | S1A | C00000619 C00001179 C00030771 | 0 / 0 |
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000619 C00001179 C00030771 | 1 / 0 |
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000619 C00001179 C00030771 | 0 / 0 |
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P30988 | Calcitonin receptor | Calcitonin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P41143 | Delta-type opioid receptor | Opioid receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| Q92731 | Estrogen receptor beta | NR3A2 | C00000619 C00001179 C00030771 | 0 / 1 |
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00000619 C00001179 C00030771 | 0 / 1 |
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000619 C00001179 C00030771 | 0 / 0 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000619 C00001179 C00030771 | 5 / 9 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000619 C00001179 C00030771 | 1 / 0 |
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000619 C00001179 C00030771 | 2 / 0 |
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00000619 C00001179 C00030771 | 1 / 0 |
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00001179 C00003741 | 0 / 0 |
| O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000619 C00030771 | 0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00000601 C00007190 | 0 / 0 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00000601 C00003741 | 0 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00000601 C00001179 | 2 / 3 |
| P02545 | Prelamin-A/C | Unclassified protein | C00001179 C00003741 | 11 / 10 |
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000619 C00030771 | 5 / 1 |
| P14679 | Tyrosinase | Oxidoreductase | C00001179 C00025324 | 4 / 2 |
| P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000619 C00030771 | 0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000601 C00031274 | 0 / 0 |
| Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00000619 C00003741 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00000601 C00001179 | 4 / 3 |
| P15121 | Aldose reductase | Enzyme | C00002682 C00003741 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000601 | 0 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00003741 | 1 / 1 |
| Q04206 | Transcription factor p65 | Transcription Factor | C00003741 | 0 / 0 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00000601 | 7 / 3 |
| P00915 | Carbonic anhydrase 1 | Lyase | C00030771 | 0 / 0 |
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00007190 | 5 / 3 |
| P10145 | Interleukin-8 | Secreted protein | C00000619 | 0 / 0 |
| P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000619 | 0 / 0 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000601 | 2 / 0 |
| Q9NWT6 | Hypoxia-inducible factor 1-alpha inhibitor | Enzyme | C00001179 | 0 / 0 |
| P42858 | Huntingtin | Unclassified protein | C00002682 | 1 / 1 |
| P08151 | Zinc finger protein GLI1 | Unclassified protein | C00003741 | 0 / 0 |
| P04745 | Alpha-amylase 1 | Enzyme | C00001179 | 0 / 0 |
| O15111 | Inhibitor of nuclear factor kappa-B kinase subunit alpha | Other serine/threonine protein kinase | C00037616 | 1 / 1 |
| Q96RI1 | Bile acid receptor | NR1H4 | C00003741 | 0 / 0 |
| Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00003741 | 0 / 0 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003741 | 0 / 0 |
| O43570 | Carbonic anhydrase 12 | Lyase | C00030771 | 1 / 2 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00000619 | 0 / 0 |
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00030771 | 0 / 0 |
| Q16790 | Carbonic anhydrase 9 | Lyase | C00030771 | 0 / 1 |
| P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00003741 | 0 / 0 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000601 | 2 / 2 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00000601 | 0 / 0 |
| Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000619 | 0 / 0 |
| Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00000619 | 0 / 0 |
| O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | C00037616 | 0 / 0 |
| Q96KS0 | Egl nine homolog 2 | Enzyme | C00001179 | 0 / 0 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003741 | 0 / 0 |
| P11387 | DNA topoisomerase 1 | Isomerase | C00003741 | 0 / 0 |
| P13674 | Prolyl 4-hydroxylase subunit alpha-1 | Enzyme | C00001179 | 0 / 0 |
| Q9GZT9 | Egl nine homolog 1 | Enzyme | C00001179 | 1 / 1 |
| P15559 | NAD(P)H dehydrogenase [quinone] 1 | Enzyme | C00003741 | 0 / 0 |
| Q02156 | Protein kinase C epsilon type | Eta | C00003741 | 0 / 0 |
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00030771 | 1 / 1 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00003741 | 0 / 0 |
| Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00003741 | 0 / 0 |
| P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00003741 | 0 / 0 |
| P05771 | Protein kinase C beta type | Alpha | C00003741 | 0 / 0 |
| P51580 | Thiopurine S-methyltransferase | Enzyme | C00002682 | 1 / 1 |
| Q9UGH3 | Solute carrier family 23 member 2 | Ascorbate | C00001179 | 0 / 0 |
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00007190 | 0 / 0 |
| P43166 | Carbonic anhydrase 7 | Lyase | C00030771 | 0 / 0 |
| P04746 | Pancreatic alpha-amylase | Hydrolase | C00001179 | 0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001179 | 0 / 0 |
| P06746 | DNA polymerase beta | Enzyme | C00003741 | 0 / 0 |
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00007190 | 0 / 0 |
| O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00003741 | 0 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003741 | 2 / 0 |
| P10275 | Androgen receptor | NR3C4 | C00000619 | 3 / 4 |
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000619 | 0 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | C00000601 | 4 / 1 |
| Q9H6Z9 | Egl nine homolog 3 | Enzyme | C00001179 | 0 / 0 |
| Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00007190 | 0 / 0 |
| O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | C00000619 | 1 / 0 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | C00030771 | 7 / 37 |
| P25963 | NF-kappa-B inhibitor alpha | Other cytosolic protein | C00037616 | 1 / 2 |
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000619 | 3 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00003741 | 0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00003741 | 1 / 0 |
| Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | C00003741 | 0 / 0 |
| Q9UBT2 | SUMO-activating enzyme subunit 2 | Enzyme | C00003741 | 0 / 0 |
| Q9UBE0 | SUMO-activating enzyme subunit 1 | Unclassified protein | C00003741 | 0 / 0 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00030771 | 0 / 0 |
| Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00007190 | 0 / 0 |
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00000601 | 1 / 1 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000619
C00001179
C00002682
|
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00001179
C00002682
|
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00001179
C00003741
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001179
C00003741
|
| 840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00001179
C00003741
|
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00001179
C00003741
|
| 54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000619
C00002682
|
| 7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00000619
C00001179
|
| 54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000619
C00001179
|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001179
C00003741
|
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000619
C00030771
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000619
C00001179
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000619
C00001179
|
| 6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00000619
C00001179
|
| 6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00000619
C00001179
|
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000619
C00001179
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000619
C00001179
|
| 5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00000619
C00001179
|
| 54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000619
C00002682
|
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000619
C00001179
|
| 23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00000619
C00001179
|
| 231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000619
C00001179
|
| 9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00000619
C00001179
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000619
C00001179
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000619
C00001179
|
| 3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000619
C00001179
|
| 3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00000619
C00001179
|
| 2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00000619
C00001179
|
| 2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00000619
C00001179
|
| 2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00000619
C00001179
|
| 9787 | DLGAP5, DLG7, HURP | discs, large (Drosophila) homolog-associated protein 5 |
C00000619
C00001179
|
| 1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00000619
C00001179
|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000619
C00001179
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000619
C00001179
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00000619
C00001179
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000619
C00001179
|
| 699 | BUB1, BUB1A, BUB1L, hBUB1 | BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) |
C00000619
C00001179
|
| 51318 | MRPL35, L35mt, MRP-L35 | mitochondrial ribosomal protein L35 |
C00000619
|
| 12095 |
C00001179
|
||
| 330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00001179
|
| 79370 | BCL2L14, BCLG | BCL2-like 14 (apoptosis facilitator) |
C00001179
|
| 768 | CA9, CAIX, MN | carbonic anhydrase IX (EC:4.2.1.1) |
C00001179
|
| 27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00001179
|
| 875 | CBS, HIP4 | cystathionine-beta-synthase (EC:4.2.1.22) |
C00001179
|
| 9212 | AURKB, AIK2, AIM-1, AIM1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5, aurkb-sv1, aurkb-sv2 | aurora kinase B (EC:2.7.11.1) |
C00001179
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00001179
|
| 894 | CCND2, KIAK0002 | cyclin D2 |
C00001179
|
| 100133941 | CD24, CD24A | CD24 molecule |
C00001179
|
| 947 | CD34 | CD34 molecule |
C00001179
|
| 958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00001179
|
| 990 | CDC6, CDC18L, HsCDC18, HsCDC6 | cell division cycle 6 |
C00001179
|
| 728642 | CDK11A, CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, PITSLRE, p58GTA | cyclin-dependent kinase 11A (EC:2.7.11.22) |
C00001179
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00001179
|
| 629 | CFB, AHUS4, BF, BFD, CFAB, FB, FBI12, GBG, H2-Bf, PBF2 | complement factor B (EC:3.4.21.47) |
C00001179
|
| 1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001179
|
| 11113 | CIT, CRIK, STK21 | citron (rho-interacting, serine/threonine kinase 21) (EC:2.7.11.1) |
C00001179
|
| 1264 | CNN1, SMCC, Sm-Calp | calponin 1, basic, smooth muscle |
C00001179
|
| 1270 | CNTF, HCNTF | ciliary neurotrophic factor |
C00001179
|
| 1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00001179
|
| 1380 | CR2, C3DR, CD21, CR, CVID7, SLEB9 | complement component (3d/Epstein Barr virus) receptor 2 |
C00001179
|
| 1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00001179
|
| 1519 | CTSO, CTSO1 | cathepsin O (EC:3.4.22.42) |
C00001179
|
| 3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00001179
|
| 6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 |
C00001179
|
| 4283 | CXCL9, CMK, Humig, MIG, SCYB9, crg-10 | chemokine (C-X-C motif) ligand 9 |
C00001179
|
| 643 | CXCR5, BLR1, CD185, MDR15 | chemokine (C-X-C motif) receptor 5 |
C00001179
|
| 79901 | CYBRD1, CYB561A2, DCYTB, FRRS3 | cytochrome b reductase 1 |
C00001179
|
| 1583 | CYP11A1, CYP11A, CYPXIA1, P450SCC | cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) |
C00001179
|
| 1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001179
|
| 467 | ATF3 | activating transcription factor 3 |
C00001179
|
| 1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00001179
|
| 1556 | CYP2B7P, CYP2B, CYP2B7, CYP2B7P1 | cytochrome P450, family 2, subfamily B, polypeptide 7, pseudogene |
C00001179
|
| 440 | ASNS, TS11 | asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) |
C00001179
|
| 22943 | DKK1, DKK-1, SK | dickkopf WNT signaling pathway inhibitor 1 |
C00001179
|
| 397 | ARHGDIB, D4, GDIA2, GDID4, LYGDI, Ly-GDI, RAP1GN1, RhoGDI2 | Rho GDP dissociation inhibitor (GDI) beta |
C00001179
|
| 54431 | DNAJC10, ERdj5, JPDI, MTHr, PDIA19 | DnaJ (Hsp40) homolog, subfamily C, member 10 |
C00001179
|
| 1773 | DNASE1, DNL1, DRNI | deoxyribonuclease I (EC:3.1.21.1) |
C00001179
|
| 1803 | DPP4, ADABP, ADCP2, CD26, DPPIV, TP103 | dipeptidyl-peptidase 4 (EC:3.4.14.5) |
C00001179
|
| 1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00001179
|
| 1908 | EDN3, ET-3, ET3, HSCR4, PPET3, WS4B | endothelin 3 |
C00001179
|
| 112399 | EGLN3, HIFP4H3, HIFPH3, PHD3 | egl-9 family hypoxia-inducible factor 3 (EC:1.14.11.29) |
C00001179
|
| 8894 | EIF2S2, EIF2, EIF2B, EIF2beta, PPP1R67, eIF-2-beta | eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa |
C00001179
|
| 8661 | EIF3A, EIF3, EIF3S10, P167, TIF32, eIF3-p170, eIF3-theta, p180, p185 | eukaryotic translation initiation factor 3, subunit A |
C00001179
|
| 8343525 |
C00001179
|
||
| 1973 | EIF4A1, DDX2A, EIF-4A, EIF4A, eIF-4A-I, eIF4A-I | eukaryotic translation initiation factor 4A1 (EC:3.6.4.13) |
C00001179
|
| 2012 | EMP1, CL-20, EMP-1, TMP | epithelial membrane protein 1 |
C00001179
|
| 2014 | EMP3, YMP | epithelial membrane protein 3 |
C00001179
|
| 2034 | EPAS1, ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73 | endothelial PAS domain protein 1 |
C00001179
|
| 2052 | EPHX1, EPHX, EPOX, HYL1, MEH | epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9) |
C00001179
|
| 2053 | EPHX2, CEH, SEH | epoxide hydrolase 2, cytoplasmic (EC:3.3.2.10 3.1.3.76) |
C00001179
|
| 2058 | EPRS, EARS, GLUPRORS, PARS, QARS, QPRS | glutamyl-prolyl-tRNA synthetase (EC:6.1.1.15 6.1.1.17) |
C00001179
|
| 2172 | FABP6, I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP | fatty acid binding protein 6, ileal |
C00001179
|
| 2321 | FLT1, FLT, FLT-1, VEGFR-1, VEGFR1 | fms-related tyrosine kinase 1 (EC:2.7.10.1) |
C00001179
|
| 2326 | FMO1 | flavin containing monooxygenase 1 (EC:1.14.13.8) |
C00001179
|
| 2330 | FMO5 | flavin containing monooxygenase 5 (EC:1.14.13.8) |
C00001179
|
| 2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00001179
|
| 2302 | FOXJ1, FKHL13, HFH-4, HFH4 | forkhead box J1 |
C00001179
|
| 2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00001179
|
| 2535 | FZD2, Fz2, fz-2, fzE2, hFz2 | frizzled family receptor 2 |
C00001179
|
| 50486 | G0S2, RP1-28O10.2 | G0/G1switch 2 |
C00001179
|
| 2580 | GAK, DNAJ26, DNAJC26 | cyclin G associated kinase (EC:2.7.11.1) |
C00001179
|
| 2617 | GARS, CMT2D, DSMAV, GlyRS, HMN5, SMAD1 | glycyl-tRNA synthetase (EC:6.1.1.14) |
C00001179
|
| 2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00001179
|
| 2674 | GFRA1, GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1 | GDNF family receptor alpha 1 |
C00001179
|
| 2744 | GLS, AAD20, GAC, GAM, GLS1, KGA | glutaminase (EC:3.5.1.2) |
C00001179
|
| 2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00001179
|
| 2877 | GPX2, GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI, GSHPx-2 | glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) |
C00001179
|
| 360 | AQP3, AQP-3, GIL | aquaporin 3 (Gill blood group) |
C00001179
|
| 351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00001179
|
| 55937 | APOM, G3a, HSPC336, NG20, apo-M | apolipoprotein M |
C00001179
|
| 2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) |
C00001179
|
| 2965 | GTF2H1, BTF2, P62, TFB1, TFIIH | general transcription factor IIH, polypeptide 1, 62kDa |
C00001179
|
| 3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00001179
|
| 9843 | HEPH, CPL | hephaestin |
C00001179
|
| 9709 | HERPUD1, HERP, Mif1, SUP | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
C00001179
|
| 338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00001179
|
| 3098 | HK1, HK1-ta, HK1-tb, HK1-tc, HKD, HKI, HMSNR, HXK1 | hexokinase 1 (EC:2.7.1.1) |
C00001179
|
| 335 | APOA1 | apolipoprotein A-I |
C00001179
|
| 3240 | HP, BP, HP2ALPHA2, HPA1S | haptoglobin |
C00001179
|
| 3283 | HSD3B1, 3BETAHSD, HSD3B, HSDB3, HSDB3A, I, SDR11E1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (EC:1.1.1.145 5.3.3.1) |
C00001179
|
| 3303 | HSPA1A, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1 | heat shock 70kDa protein 1A |
C00001179
|
| 3309 | HSPA5, BIP, GRP78, MIF2 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
C00001179
|
| 3313 | HSPA9, CSA, GRP-75, GRP75, HSPA9B, MOT, MOT2, MTHSP75, PBP74 | heat shock 70kDa protein 9 (mortalin) |
C00001179
|
| 3315 | HSPB1, CMT2F, HMN2B, HS.76067, HSP27, HSP28, Hsp25, SRP27 | heat shock 27kDa protein 1 |
C00001179
|
| 3347 | HTN3, HIS2, HTN2, HTN5 | histatin 3 |
C00001179
|
| 3376 | IARS, IARS1, ILERS, ILRS, IRS, PRO0785 | isoleucyl-tRNA synthetase (EC:6.1.1.5) |
C00001179
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00001179
|
| 8870 | IER3, DIF-2, DIF2, GLY96, IEX-1, IEX-1L, IEX1, PRG1 | immediate early response 3 |
C00001179
|
| 3488 | IGFBP5, IBP5 | insulin-like growth factor binding protein 5 |
C00001179
|
| 10320 | IKZF1, Hs.54452, IK1, IKAROS, LYF1, PRO0758, ZNFN1A1, hIk-1 | IKAROS family zinc finger 1 (Ikaros) |
C00001179
|
| 301 | ANXA1, ANX1, LPC1 | annexin A1 |
C00001179
|
| 290 | ANPEP, APN, CD13, GP150, LAP1, P150, PEPN | alanyl (membrane) aminopeptidase (EC:3.4.11.2) |
C00001179
|
| 3745 | KCNB1, DRK1, KV2.1, h-DRK1 | potassium voltage-gated channel, Shab-related subfamily, member 1 |
C00001179
|
| 3791 | KDR, CD309, FLK1, VEGFR, VEGFR2 | kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) |
C00001179
|
| 248 | ALPI, IAP | alkaline phosphatase, intestinal (EC:3.1.3.1) |
C00001179
|
| 3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) |
C00001179
|
| 3956 | LGALS1, GAL1, GBP | lectin, galactoside-binding, soluble, 1 |
C00001179
|
| 4017 | LOXL2, LOR2, WS9-14 | lysyl oxidase-like 2 (EC:1.4.3.-) |
C00001179
|
| 4067 | LYN, JTK8, p53Lyn, p56Lyn | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2) |
C00001179
|
| 112 | ADCY6, AC6 | adenylate cyclase 6 (EC:4.6.1.1) |
C00001179
|
| 10892 | MALT1, IMD12, MLT, MLT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 (EC:3.4.22.-) |
C00001179
|
| 5606 | MAP2K3, MAPKK3, MEK3, MKK3, PRKMK3, SAPKK-2, SAPKK2 | mitogen-activated protein kinase kinase 3 (EC:2.7.12.2) |
C00001179
|
| 5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) |
C00001179
|
| 4217 | MAP3K5, ASK1, MAPKKK5, MEKK5 | mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25) |
C00001179
|
| 1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00001179
|
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00001179
|
| 5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00001179
|
| 4173 | MCM4, CDC21, CDC54, NKCD, NKGCD, P1-CDC21, hCdc21 | minichromosome maintenance complex component 4 (EC:3.6.4.12) |
C00001179
|
| 4224 | MEP1A, PPHA | meprin A, alpha (PABA peptide hydrolase) (EC:3.4.24.18) |
C00001179
|
| 4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00001179
|
| 4288 | MKI67, KIA, MIB-1 | marker of proliferation Ki-67 |
C00001179
|
| 4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00001179
|
| 4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00001179
|
| 4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00001179
|
| 4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00001179
|
| 4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00001179
|
| 4485 | MST1, D3F15S2, DNF15S2, HGFL, MSP, NF15S2 | macrophage stimulating 1 (hepatocyte growth factor-like) |
C00001179
|
| 11223 | MST1L, BRF-1, D1F15S1A, MSPL-7, MSPL7, MST1P9, MSTP7, MSTP9 | macrophage stimulating 1-like |
C00001179
|
| 4504 | MT3, GIF, GIFB, GRIF, ZnMT3 | metallothionein 3 |
C00001179
|
| 10797 | MTHFD2, NMDMC | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase (EC:3.5.4.9 1.5.1.15) |
C00001179
|
| 4605 | MYBL2, B-MYB, BMYB | v-myb avian myeloblastosis viral oncogene homolog-like 2 |
C00001179
|
| 4640 | MYO1A, BBMI, DFNA48, MIHC, MYHL | myosin IA |
C00001179
|
| 4677 | NARS, ASNRS, NARS1 | asparaginyl-tRNA synthetase (EC:6.1.1.22) |
C00001179
|
| 10397 | NDRG1, CAP43, CMT4D, DRG-1, DRG1, GC4, HMSNL, NDR1, NMSL, PROXY1, RIT42, RTP, TARG1, TDD5 | N-myc downstream regulated 1 |
C00001179
|
| 59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta |
C00001179
|
| 4800 | NFYA, CBF-A, CBF-B, HAP2, NF-YA | nuclear transcription factor Y, alpha |
C00001179
|
| 4814 | NINJ1, NIN1, NINJURIN | ninjurin 1 |
C00001179
|
| 7080 | NKX2-1, BCH, BHC, NK-2, NKX2.1, NKX2A, TEBP, TITF1, TTF-1, TTF1 | NK2 homeobox 1 |
C00001179
|
| 4830 | NME1, AWD, GAAD, NB, NBS, NDKA, NDPK-A, NDPKA, NM23, NM23-H1 | NME/NM23 nucleoside diphosphate kinase 1 (EC:2.7.4.6) |
C00001179
|
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001179
|
| 59272 | ACE2, ACEH | angiotensin I converting enzyme 2 (EC:3.4.17.23) |
C00001179
|
| 2908 | NR3C1, GCCR, GCR, GR, GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
C00001179
|
| 8013 | NR4A3, CHN, CSMF, MINOR, NOR1, TEC | nuclear receptor subfamily 4, group A, member 3 |
C00001179
|
| 4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00001179
|
| 10956 | OS9, ERLEC2, OS-9 | osteosarcoma amplified 9, endoplasmic reticulum lectin |
C00001179
|
| 8974 | P4HA2 | prolyl 4-hydroxylase, alpha polypeptide II (EC:1.14.11.2) |
C00001179
|
| 54681 | P4HTM, EGLN4, HIFPH4, P4H-TM, PH-4, PH4, PHD4 | prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
C00001179
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001179
|
| 5106 | PCK2, PEPCK, PEPCK-M, PEPCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) (EC:4.1.1.32) |
C00001179
|
| 64714 | PDIA2, PDA2, PDI, PDIP, PDIR | protein disulfide isomerase family A, member 2 (EC:5.3.4.1) |
C00001179
|
| 2923 | PDIA3, ER60, ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC | protein disulfide isomerase family A, member 3 (EC:5.3.4.1) |
C00001179
|
| 26227 | PHGDH, 3-PGDH, 3PGDH, PDG, PGAD, PGD, PGDH, SERA | phosphoglycerate dehydrogenase (EC:1.1.1.95) |
C00001179
|
| 22822 | PHLDA1, DT1P1B11, PHRIP, TDAG51 | pleckstrin homology-like domain, family A, member 1 |
C00001179
|
| 7262 | PHLDA2, BRW1C, BWR1C, HLDA2, IPL, TSSC3 | pleckstrin homology-like domain, family A, member 2 |
C00001179
|
| 11145 | PLA2G16, AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-1, HREV107-3, HRSL3 | phospholipase A2, group XVI (EC:3.1.1.4 3.1.1.32) |
C00001179
|
| 5340 | PLG | plasminogen (EC:3.4.21.7) |
C00001179
|
| 5347 | PLK1, PLK, STPK13 | polo-like kinase 1 (EC:2.7.11.21) |
C00001179
|
| 1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00001179
|
| 5376 | PMP22, CMT1A, CMT1E, DSS, GAS-3, HMSNIA, HNPP, Sp110 | peripheral myelin protein 22 |
C00001179
|
| 5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00001179
|
| 5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) |
C00001179
|
| 5460 | POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4 | POU class 5 homeobox 1 |
C00001179
|
| 10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001179
|
| 5588 | PRKCQ, PRKCT, nPKC-theta | protein kinase C, theta (EC:2.7.11.13) |
C00001179
|
| 38175 |
C00001179
|
||
| 5702 | PSMC3, TBP1 | proteasome (prosome, macropain) 26S subunit, ATPase, 3 |
C00001179
|
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00001179
|
| 5865 | RAB3B | RAB3B, member RAS oncogene family |
C00001179
|
| 5870 | RAB6A, RAB6 | RAB6A, member RAS oncogene family |
C00001179
|
| 5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00001179
|
| 5889 | RAD51C, BROVCA3, FANCO, R51H3, RAD51L2 | RAD51 paralog C |
C00001179
|
| 25788 | RAD54B, RDH54 | RAD54 homolog B (S. cerevisiae) |
C00001179
|
| 1827 | RCAN1, ADAPT78, CSP1, DSC1, DSCR1, MCIP1, RCN1 | regulator of calcineurin 1 |
C00001179
|
| 860 | RUNX2, AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD, OSF-2, OSF2, PEA2aA, PEBP2aA | runt-related transcription factor 2 |
C00001179
|
| 795 | S100G, CABP, CABP1, CABP9K, CALB3 | S100 calcium binding protein G |
C00001179
|
| 5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
C00001179
|
| 83667 | SESN2, HI95, SES2, SEST2 | sestrin 2 |
C00001179
|
| 6439 | SFTPB, PSP-B, SFTB3, SFTP3, SMDP1, SP-B | surfactant protein B |
C00001179
|
| 6472 | SHMT2, GLYA, SHMT | serine hydroxymethyltransferase 2 (mitochondrial) (EC:2.1.2.1) |
C00001179
|
| 6476 | SI | sucrase-isomaltase (alpha-glucosidase) (EC:3.2.1.10 3.2.1.48) |
C00001179
|
| 4891 | SLC11A2, DCT1, DMT1, NRAMP2 | solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 |
C00001179
|
| 10864 | SLC22A7, NLT, OAT2 | solute carrier family 22 (organic anion transporter), member 7 |
C00001179
|
| 9963 | SLC23A1, SLC23A2, SVCT1, YSPL3 | solute carrier family 23 (ascorbic acid transporter), member 1 |
C00001179
|
| 9962 | SLC23A2, NBTL1, SLC23A1, SVCT2, YSPL2 | solute carrier family 23 (ascorbic acid transporter), member 2 |
C00001179
|
| 79677 | SMC6, SMC-6, SMC6L1, hSMC6 | structural maintenance of chromosomes 6 |
C00001179
|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00001179
|
| 19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00001179
|
| 6657 | SOX2, ANOP3, MCOPS3 | SRY (sex determining region Y)-box 2 |
C00001179
|
| 6667 | SP1 | Sp1 transcription factor |
C00001179
|
| 6670 | SP3, SPR2 | Sp3 transcription factor |
C00001179
|
| 6671 | SP4, HF1B, SPR-1 | Sp4 transcription factor |
C00001179
|
| 6678 | SPARC, ON | secreted protein, acidic, cysteine-rich (osteonectin) |
C00001179
|
| 6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00001179
|
| 16 | AARS, CMT2N | alanyl-tRNA synthetase (EC:6.1.1.7) |
C00001179
|
| 6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00001179
|
| 9262 | STK17B, DRAK2 | serine/threonine kinase 17b (EC:2.7.11.1) |
C00001179
|
| 6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00001179
|
| 6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00001179
|
| 20888 |
C00001179
|
||
| 6822 | SULT2A1, DHEA-ST, DHEAS, HST, ST2, ST2A1, ST2A3, STD, hSTa | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 (EC:2.8.2.14) |
C00001179
|
| 6876 | TAGLN, SM22, SMCC, TAGLN1, WS3-10 | transgelin |
C00001179
|
| 6897 | TARS, ThrRS | threonyl-tRNA synthetase (EC:6.1.1.3) |
C00001179
|
| 6901 | TAZ, BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX, Taz1 | tafazzin |
C00001179
|
| 7018 | TF, PRO1557, PRO2086, TFQTL1 | transferrin |
C00001179
|
| 7032 | TFF2, SML1, SP | trefoil factor 2 |
C00001179
|
| 7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00001179
|
| 7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00001179
|
| 4071 | TM4SF1, H-L6, L6, M3S1, TAAL6 | transmembrane 4 L six family member 1 |
C00001179
|
| 164656 | TMPRSS6, IRIDA | transmembrane protease, serine 6 |
C00001179
|
| 7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00030771
|
| 4982 | TNFRSF11B, OCIF, OPG, TR1 | tumor necrosis factor receptor superfamily, member 11b |
C00001179
|
| 8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00001179
|
| 3952 | LEP, LEPD, OB, OBS | leptin |
C00030771
|
| 11257 | TP53TG1, LINC00096, NCRNA00096, P53TG1, P53TG1-D, TP53AP1 | TP53 target 1 (non-protein coding) |
C00001179
|
| 57761 | TRIB3, C20orf97, NIPK, SINK, SKIP3, TRB3 | tribbles pseudokinase 3 |
C00001179
|
| 9322 | TRIP10, CIP4, HSTP, STOT, STP | thyroid hormone receptor interactor 10 |
C00001179
|
| 7224 | TRPC5, TRP5 | transient receptor potential cation channel, subfamily C, member 5 |
C00001179
|
| 7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00001179
|
| 7319 | UBE2A, HHR6A, MRXS30, MRXSN, RAD6A, UBC2 | ubiquitin-conjugating enzyme E2A (EC:6.3.2.19) |
C00001179
|
| 7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00003741
|
| 7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00003741
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00003741
|
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00001179
|
| 7428 | VHL, HRCA1, RCA1, VHL1, pVHL | von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
C00001179
|
| 55350 | VNN3, HSA238982 | vanin 3 |
C00001179
|
| 7443 | VRK1, PCH1, PCH1A | vaccinia related kinase 1 (EC:2.7.11.1) |
C00001179
|
| 7453 | WARS, GAMMA-2, IFI53, IFP53 | tryptophanyl-tRNA synthetase (EC:6.1.1.2) |
C00001179
|
| 10352 | WARS2, TrpRS | tryptophanyl tRNA synthetase 2, mitochondrial (EC:6.1.1.2) |
C00001179
|
| 25937 | WWTR1, TAZ | WW domain containing transcription regulator 1 |
C00001179
|
| 7512 | XPNPEP2, APP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound (EC:3.4.11.9) |
C00001179
|
| 7515 | XRCC1, RCC | X-ray repair complementing defective repair in Chinese hamster cells 1 |
C00001179
|
| 7718 | ZNF165, CT53, LD65, ZSCAN7 | zinc finger protein 165 |
C00001179
|
| 23460 | ABCA6, EST155051 | ATP-binding cassette, sub-family A (ABC1), member 6 |
C00000619
|
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000619
|
| 57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00000619
|
| 1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000619
|
| 8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000619
|
| 249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00000619
|
| 367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000619
|
| 55114 | ARHGAP17, MST066, MST110, MSTP038, MSTP066, MSTP110, NADRIN, PP367, PP4534, RICH1, RICH1B, WBP15 | Rho GTPase activating protein 17 |
C00000619
|
| 10123 | ARL4C, ARL7, LAK | ADP-ribosylation factor-like 4C |
C00000619
|
| 567 | B2M | beta-2-microglobulin |
C00000619
|
| 9774 | BCLAF1, BTF, bK211L9.1 | BCL2-associated transcription factor 1 |
C00000619
|
| 654 | BMP6, VGR, VGR1 | bone morphogenetic protein 6 |
C00000619
|
| 57102 | C12orf4 | chromosome 12 open reading frame 4 |
C00000619
|
| 10203 | CALCRL, CGRPR, CRLR | calcitonin receptor-like |
C00000619
|
| 6357 | CCL13, CKb10, MCP-4, NCC-1, NCC1, SCYA13, SCYL1 | chemokine (C-C motif) ligand 13 |
C00000619
|
| 6363 | CCL19, CKb11, ELC, MIP-3b, MIP3B, SCYA19 | chemokine (C-C motif) ligand 19 |
C00000619
|
| 6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00000619
|
| 6349 | CCL3L1, 464.2, D17S1718, G0S19-2, LD78, LD78BETA, MIP1AP, SCYA3L, SCYA3L1 | chemokine (C-C motif) ligand 3-like 1 |
C00000619
|
| 6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00000619
|
| 729230 | CCR2, CC-CKR-2, CCR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, MCP-1-R | chemokine (C-C motif) receptor 2 |
C00000619
|
| 1234 | CCR5, CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
C00000619
|
| 1236 | CCR7, BLR2, CD197, CDw197, CMKBR7, EBI1 | chemokine (C-C motif) receptor 7 |
C00000619
|
| 948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00000619
|
| 942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00000619
|
| 1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00000619
|
| 1390 | CREM, CREM-2, ICER, hCREM-2 | cAMP responsive element modulator |
C00000619
|
| 1514 | CTSL, CATL, CTSL1, MEP | cathepsin L (EC:3.4.22.15) |
C00000619
|
| 2919 | CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
C00000619
|
| 7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00000619
|
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000619
|
| 1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00000619
|
| 1593 | CYP27A1, CP27, CTX, CYP27 | cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) |
C00000619
|
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000619
|
| 1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00000619
|
| 1736 | DKC1, CBF5, DKC, DKCX, NAP57, NOLA4, XAP101 | dyskeratosis congenita 1, dyskerin |
C00000619
|
| 1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00000619
|
| 1870 | E2F2, E2F-2 | E2F transcription factor 2 |
C00000619
|
| 1871 | E2F3, E2F-3 | E2F transcription factor 3 |
C00000619
|
| 1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding |
C00000619
|
| 1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding |
C00000619
|
| 1876 | E2F6, E2F-6 | E2F transcription factor 6 |
C00000619
|
| 1959 | EGR2, AT591, CMT1D, CMT4E, KROX20 | early growth response 2 |
C00000619
|
| 133418 | EMB | embigin |
C00000619
|
| 2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000619
|
| 2162 | F13A1, F13A | coagulation factor XIII, A1 polypeptide (EC:2.3.2.13) |
C00000619
|
| 26268 | FBXO9, FBX9, NY-REN-57, VCIA1, dJ341E18.2 | F-box protein 9 |
C00000619
|
| 2213 | FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2 | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
C00000619
|
| 2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00000619
|
| 2355 | FOSL2, FRA2 | FOS-like antigen 2 |
C00000619
|
| 2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00000619
|
| 2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00000619
|
| 2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00000619
|
| 2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00000619
|
| 644076 | GLYCAM1 | glycosylation dependent cell adhesion molecule 1 (pseudogene) |
C00000619
|
| 2878 | GPX3, GPx-P, GSHPx-3, GSHPx-P | glutathione peroxidase 3 (plasma) (EC:1.11.1.9) |
C00000619
|
| 2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00000619
|
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000619
|
| 2994 | GYPB, CD235b, GPB, GPB.NY, GYPHe.NY, GpMiIII, HGpMiIII, HGpMiVI, HGpMiX, MNS, PAS-3, SS | glycophorin B (MNS blood group) |
C00000619
|
| 54497 | HEATR5B | HEAT repeat containing 5B |
C00000619
|
| 3106 | HLA-B, AS, HLAB, SPDA1 | major histocompatibility complex, class I, B |
C00000619
|
| 220988 | HNRNPA3, 2610510D13Rik, D10S102, FBRNP, HNRPA3 | heterogeneous nuclear ribonucleoprotein A3 |
C00000619
|
| 3381 | IBSP, BNSP, BSP, BSP-II, SP-II | integrin-binding sialoprotein |
C00000619
|
| 3422 | IDI1, IPP1, IPPI1 | isopentenyl-diphosphate delta isomerase 1 (EC:5.3.3.2) |
C00000619
|
| 7850 | IL1R2, CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c, IL1RB | interleukin 1 receptor, type II |
C00000619
|
| 3575 | IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA | interleukin 7 receptor |
C00000619
|
| 26034 | IPCEF1, PIP3-E, RP3-402L9.2 | interaction protein for cytohesin exchange factors 1 |
C00000619
|
| 3655 | ITGA6, CD49f, ITGA6B, VLA-6 | integrin, alpha 6 |
C00000619
|
| 3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00000619
|
| 3741 | KCNA5, ATFB7, HCK1, HK2, HPCN1, KV1.5, PCN1 | potassium voltage-gated channel, shaker-related subfamily, member 5 |
C00000619
|
| 3759 | KCNJ2, ATFB9, HHBIRK1, HHIRK1, IRK1, KIR2.1, LQT7, SQT3 | potassium inwardly-rectifying channel, subfamily J, member 2 |
C00000619
|
| 4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00000619
|
| 7975 | MAFK, NFE2U, P18 | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K |
C00000619
|
| 28985 | MCTS1, MCT-1, MCT1 | malignant T cell amplified sequence 1 |
C00000619
|
| 4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00000619
|
| 4257 | MGST1, GST12, MGST, MGST-I | microsomal glutathione S-transferase 1 (EC:2.5.1.18) |
C00000619
|
| 632 | BGLAP, BGP, OC, OCN | bone gamma-carboxyglutamate (gla) protein |
C00001179
|
| 58475 | MS4A7, 4SPAN2, CD20L4, CFFM4, MS4A8 | membrane-spanning 4-domains, subfamily A, member 7 |
C00000619
|
| 4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00000619
|
| 4084 | MXD1, BHLHC58, MAD, MAD1 | MAX dimerization protein 1 |
C00000619
|
| 4602 | MYB, Cmyb, c-myb, c-myb_CDS, efg | v-myb avian myeloblastosis viral oncogene homolog |
C00000619
|
| 10135 | NAMPT, 1110035O14Rik, PBEF, PBEF1, VF, VISFATIN | nicotinamide phosphoribosyltransferase (EC:2.4.2.12) |
C00000619
|
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00000619
|
| 1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000619
|
| 4927 | NUP88 | nucleoporin 88kDa |
C00000619
|
| 10606 | PAICS, ADE2, ADE2H1, AIRC, PAIS | phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (EC:6.3.2.6 4.1.1.21) |
C00000619
|
| 5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00000619
|
| 5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00000619
|
| 8301 | PICALM, CALM, CLTH, LAP | phosphatidylinositol binding clathrin assembly protein |
C00000619
|
| 5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00000619
|
| 5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00000619
|
| 10935 | PRDX3, AOP-1, AOP1, HBC189, MER5, PRO1748, SP-22, prx-III | peroxiredoxin 3 (EC:1.11.1.15) |
C00000619
|
| 5733 | PTGER3, EP3, EP3-I, EP3-II, EP3-III, EP3-IV, EP3e, PGE2-R | prostaglandin E receptor 3 (subtype EP3) |
C00000619
|
| 22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00000619
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000619
|
| 5996 | RGS1, 1R20, BL34, IER1, IR20 | regulator of G-protein signaling 1 |
C00000619
|
| 6157 | RPL27A, L27A | ribosomal protein L27a |
C00000619
|
| 50484 | RRM2B, MTDPS8A, MTDPS8B, P53R2 | ribonucleotide reductase M2 B (TP53 inducible) (EC:1.17.4.1) |
C00000619
|
| 6303 | SAT1, DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1 | spermidine/spermine N1-acetyltransferase 1 (EC:2.3.1.57) |
C00000619
|
| 6383 | SDC2, CD362, HSPG, HSPG1, SYND2 | syndecan 2 |
C00000619
|
| 55752 | SEPT11 | septin 11 |
C00000619
|
| 6504 | SLAMF1, CD150, CDw150, SLAM | signaling lymphocytic activation molecule family member 1 |
C00000619
|
| 117247 | SLC16A10, MCT10, PRO0813, TAT1 | solute carrier family 16 (aromatic amino acid transporter), member 10 |
C00000619
|
| 6515 | SLC2A3, GLUT3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
C00000619
|
| 6649 | SOD3, EC-SOD | superoxide dismutase 3, extracellular (EC:1.15.1.1) |
C00000619
|
| 140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00000619
|
| 6775 | STAT4, SLEB11 | signal transducer and activator of transcription 4 |
C00000619
|
| 6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00000619
|
| 7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000619
|
| 7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00000619
|
| 7130 | TNFAIP6, TSG-6, TSG6 | tumor necrosis factor, alpha-induced protein 6 |
C00000619
|
| 8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00000619
|
| 162514 | TRPV3, OLMS, VRL3 | transient receptor potential cation channel, subfamily V, member 3 |
C00000619
|
| 25828 | TXN2, MT-TRX, MTRX, TRX2 | thioredoxin 2 |
C00000619
|
| 7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000619
|
| 10587 | TXNRD2, SELZ, TR, TR-BETA, TR3, TRXR2 | thioredoxin reductase 2 (EC:1.8.1.9) |
C00000619
|
| 7358 | UGDH, GDH, UDP-GlcDH, UDPGDH, UGD | UDP-glucose 6-dehydrogenase (EC:1.1.1.22) |
C00000619
|
| 54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000619
|
| 54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00000619
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00003741
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00003741
|
| 7367 | UGT2B17, BMND12, UDPGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 (EC:2.4.1.17) |
C00000619
|
| 7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00000619
|
| 7709 | ZBTB17, MIZ-1, ZNF151, ZNF60, pHZ-67 | zinc finger and BTB domain containing 17 |
C00000619
|
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002682
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #103780 | Alcohol dependence |
P08172
P14416 P31645 |
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
| #602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
| %606641 | Body mass index; bmi |
P37231
|
| #612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
| #300615 | Brunner syndrome |
P21397
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #609338 | Carotid intimal medial thickness 1 |
P37231
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #613630 | Cocoon syndrome |
O15111
|
| #114500 | Colorectal cancer; crc |
P84022
|
| #218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
| #606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
| #162800 | Cyclic neutropenia |
P08246
|
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #612132 | Ectodermal dysplasia, anhidrotic, with t-cell immunodeficiency, autosomal dominant |
P25963
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
| #133239 | Esophageal cancer |
P04637
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
| #143500 | Gilbert syndrome |
P22309
P22310 |
| #137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
| #143100 | Huntington disease; hd |
P42858
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
| #143860 | Hyperchlorhidrosis, isolated |
O43570
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #608516 | Major depressive disorder; mdd |
P08172
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| %300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #159900 | Myoclonic dystonia |
P14416
|
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
| #601665 | Obesity |
P32245
P37231 |
| #164230 | Obsessive-compulsive disorder; ocd |
P31645
|
| #604715 | Orthostatic intolerance |
P23975
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #167000 | Ovarian cancer |
P04626
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #607276 | Resting heart rate, variation in |
P08588
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #610460 | Thiopurine s-methyltransferase deficiency |
P51580
|
| #190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #610379 | West nile virus, susceptibility to |
P51681
|
| #278300 | Xanthinuria, type i |
P47989
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00882 | Cocoon syndrome |
O15111
(related)
|
| H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
| H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
| H00033 | Adrenal carcinoma |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
| H00079 | Asthma |
P07550
(related)
|
| H00100 | Neutropenic disorders |
P08246
(related)
|
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00548 | Brunner syndrome |
P21397
(related)
|
| H00208 | Hyperbilirubinemia |
P22309
(related)
|
| H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
| H00007 | Hodgkin lymphoma |
P25963
(related)
|
| H00095 | Ectodermal dysplasia associated immunodeficiency (EDA-ID) |
P25963
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00409 | Type II diabetes mellitus |
P37231
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00192 | Xanthinuria |
P47989
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
| H00964 | Thiopurine S-methyltransferase deficiency (TPMT deficiency) |
P51580
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
| H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D056486 | Drug-Induced Liver Injury |
C00001179
C00000619 C00003467 |
| D009410 | Nerve Degeneration |
C00001179
C00000619 |
| D013276 | Stomach Ulcer |
C00001179
C00000619 |
| D002375 | Catalepsy |
C00000601
C00001179 |
| D013274 | Stomach Neoplasms |
C00001179
C00000619 |
| D010149 | Pain, Postoperative |
C00001179
C00000619 |
| D008545 | Melanoma |
C00003741
C00000619 |
| D009374 | Neoplasms, Experimental |
C00001179
C00000619 |
| D009336 | Necrosis |
C00001179
C00003467 |
| D006965 | Hyperplasia |
C00001179
C00003467 |
| D008103 | Liver Cirrhosis |
C00003741
C00001179 |
| D001943 | Breast Neoplasms |
C00001179
C00000619 |
| D012614 | Scurvy |
C00001179
|
| D000756 | Anemia, Sideroblastic |
C00001179
|
| D001206 | Ascorbic Acid Deficiency |
C00001179
|
| D001424 | Bacterial Infections |
C00001179
|
| D001766 | Blindness |
C00001179
|
| D001847 | Bone Diseases |
C00001179
|
| D001927 | Brain Diseases |
C00001179
|
| D002545 | Brain Ischemia |
C00001179
|
| D018798 | Anemia, Iron-Deficiency |
C00001179
|
| D002277 | Carcinoma |
C00001179
|
| D006528 | Carcinoma, Hepatocellular |
C00001179
|
| D009202 | Cardiomyopathies |
C00001179
|
| D018376 | Cardiovascular Abnormalities |
C00001179
|
| D002318 | Cardiovascular Diseases |
C00001179
|
| D002386 | Cataract |
C00001179
|
| D002471 | Cell Transformation, Neoplastic |
C00001179
|
| D002607 | Charcot-Marie-Tooth Disease |
C00001179
|
| D002869 | Chromosome Aberrations |
C00001179
|
| D003139 | Common Cold |
C00001179
|
| D020918 | Complex Regional Pain Syndromes |
C00001179
|
| D003327 | Coronary Disease |
C00001179
|
| D003681 | Dehydration |
C00001179
|
| D003924 | Diabetes Mellitus, Type 2 |
C00001179
|
| D003928 | Diabetic Nephropathies |
C00001179
|
| D003930 | Diabetic Retinopathy |
C00001179
|
| D000740 | Anemia |
C00001179
|
| D062787 | Drug Overdose |
C00001179
|
| D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001179
|
| C538011 | Eales disease |
C00001179
|
| D004890 | Erythema |
C00001179
|
| D005221 | Fatigue |
C00001179
|
| D006029 | Glycosuria |
C00001179
|
| D006130 | Growth Disorders |
C00001179
|
| D006212 | Hallucinations |
C00001179
|
| D006330 | Heart Defects, Congenital |
C00001179
|
| D006548 | Hernia, Diaphragmatic |
C00001179
|
| D015658 | HIV Infections |
C00001179
|
| D006959 | Hyperoxaluria |
C00001179
|
| D000647 | Amnesia |
C00001179
|
| D006973 | Hypertension |
C00001179
|
| D006977 | Hypertension, Renal |
C00001179
|
| D007022 | Hypotension |
C00001179
|
| D007037 | Hypothyroidism |
C00001179
|
| 146850 | IMMUNE SUPPRESSION |
C00001179
|
| D007674 | Kidney Diseases |
C00001179
|
| D007683 | Kidney Tubular Necrosis, Acute |
C00001179
|
| D007859 | Learning Disorders |
C00001179
|
| D007945 | Leukemia, Lymphoid |
C00001179
|
| D008114 | Liver Neoplasms, Experimental |
C00001179
|
| D008171 | Lung Diseases |
C00001179
|
| D008175 | Lung Neoplasms |
C00001179
|
| D020149 | Manganese Poisoning |
C00001179
|
| D008630 | Mercury Poisoning |
C00001179
|
| D048629 | Micronuclei, Chromosome-Defective |
C00001179
|
| D009120 | Muscle Cramp |
C00001179
|
| D009135 | Muscular Diseases |
C00001179
|
| D009203 | Myocardial Infarction |
C00001179
|
| D009325 | Nausea |
C00001179
|
| D055371 | Acute Lung Injury |
C00001179
|
| D009369 | Neoplasms |
C00001179
|
| D058186 | Acute Kidney Injury |
C00001179
|
| D009395 | Nephritis, Interstitial |
C00001179
|
| D053040 | Nephrolithiasis |
C00001179
|
| D020734 | Parkinsonian Disorders |
C00000601
|
| D009422 | Nervous System Diseases |
C00001179
|
| D009765 | Obesity |
C00001179
|
| D009845 | Oligospermia |
C00001179
|
| D020244 | Infarction, Middle Cerebral Artery |
C00000601
|
| D010212 | Papilloma |
C00001179
|
| D016491 | Peripheral Vascular Diseases |
C00001179
|
| D011041 | Poisoning |
C00001179
|
| D011230 | Precancerous Conditions |
C00001179
|
| D011471 | Prostatic Neoplasms |
C00001179
|
| D011507 | Proteinuria |
C00001179
|
| D011561 | Pseudoxanthoma Elasticum |
C00001179
|
| D011605 | Psychoses, Substance-Induced |
C00001179
|
| D011654 | Pulmonary Edema |
C00001179
|
| D011657 | Pulmonary Eosinophilia |
C00001179
|
| D011658 | Pulmonary Fibrosis |
C00001179
|
| D051437 | Renal Insufficiency |
C00001179
|
| D012174 | Retinitis Pigmentosa |
C00001179
|
| D000749 | Anemia, Megaloblastic |
C00001179
|
| D012640 | Seizures |
C00001179
|
| D012871 | Skin Diseases |
C00001179
|
| D013226 | Status Epilepticus |
C00001179
|
| D018476 | Hypokinesia |
C00000601
|
| D001930 | Brain Injuries |
C00000601
|
| D020521 | Stroke |
C00001179
|
| D013375 | Substance Withdrawal Syndrome |
C00001179
|
| D013921 | Thrombocytopenia |
C00001179
|
| D001749 | Urinary Bladder Neoplasms |
C00001179
|
| D017449 | Dermatitis, Allergic Contact |
C00000619
|
| D003877 | Dermatitis, Contact |
C00000619
|
| D003875 | Drug Eruptions |
C00000619
|
| D006331 | Heart Diseases |
C00000619
|
| D006461 | Hemolysis |
C00000619
|
| D006930 | Hyperalgesia |
C00000619
|
| D006967 | Hypersensitivity |
C00000619
|
| D007249 | Inflammation |
C00000619
|
| D009361 | Neoplasm Invasiveness |
C00000619
|
| D009362 | Neoplasm Metastasis |
C00000619
|
| D009389 | Neovascularization, Pathologic |
C00000619
|
| D010146 | Pain |
C00000619
|
| D010300 | Parkinson Disease |
C00000619
|
| D011833 | Radiation Injuries, Experimental |
C00000619
|
| D012481 | Salmonella Infections, Animal |
C00000619
|
| D012878 | Skin Neoplasms |
C00000619
|
| D013035 | Spasm |
C00000619
|
| D013203 | Staphylococcal Infections |
C00000619
|
| D014581 | Urticaria |
C00000619
|
| D002583 | Uterine Cervical Neoplasms |
C00000619
|
| D006984 | Hypertrophy |
C00003467
|
| D015431 | Weight Loss |
C00003467
|